newsfilter
← Latest News
Business Wire·

Tetraphase Pharmaceuticals Announces Reverse Stock Split

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline for injection) to treat serious and life-threatening infections, announced today that it will effect a 1-for-20 reverse stock split of its common stock that will be effective at 5:00 p.m. Eastern Time today. The Company's common stock will begin trading on a split-adjusted basis when the market opens on September 27, 2019 under the existing symbol “TTPH”.